-
-
-
-
-
-
-
Innoviva (INVA) Announces Publication of Results from Phase 3 ATTACK Trial
-
-
-
-
-
-
-
Innoviva (INVA) Announces FDA Advisory Committee Meeting to Review Sulbactam-Durlobactam
-
-
-
-
15,420 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

